Exeter Resource Corp  

(Public, NYSEMKT:XRA)   Watch this stock  
Find more results for XRA
+0.03 (1.86%)
Jun 23 - Close
NYSEMKT real-time data - Disclaimer
Currency in USD
Range 1.61 - 1.65
52 week 0.66 - 1.89
Open 1.61
Vol / Avg. 51,619.00/165,809.00
Mkt cap 157.17M
P/E     -
Div/yield     -
EPS -0.08
Shares 92.72M
Beta -0.44
Inst. own 32%
Apr 6, 2017
Exeter Resource Corp at Denver Gold European Gold Forum
Mar 31, 2017
Q4 2016 Exeter Resource Corp Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '17) 2016
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -134.30% -29.63%
Return on average equity -149.24% -30.29%
Employees 17 -
CDP Score - -


999 Hastings St W Suite 1660, P.O.Box 41
+1-604-6889592 (Phone)
+1-604-6889532 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Exeter Resource Corporation is an exploration-stage company. The Company operates as a mineral resource exploration and development company. It is engaged in the business of acquisition, exploration and development of mineral properties located in the Maricunga Region, Chile. It operates through the mineral property acquisition, exploration and development segment. Its principal property is the Caspiche property in northern Chile. The Company is also evaluating new opportunities with the objective of securing properties. It is in the process of exploring its mineral properties. The Caspiche project is located high in the central Chilean Andes. The property is located approximately 120 kilometers East-southeast of Copiapo in northern Chile and is situated at the southern end of the Maricunga metallogenic belt, between the undeveloped Cerro Casale gold-copper project approximately 12 kilometers to the south, and the operating Maricunga Gold Mine.

Officers and directors

Bryce G. Roxburgh Co-Chairman of the Board
Age: 64
Bio & Compensation  - Reuters
Yale Ronald Simpson Co-Chairman of the Board
Bio & Compensation  - Reuters
Wendell M. Zerb President, Chief Executive Officer
Bio & Compensation  - Reuters
Cecil R. Bond Chief Financial Officer
Bio & Compensation  - Reuters
S. R. Jeremy Perkins Vice President - Development and Operations
Bio & Compensation  - Reuters
Julian Richard Frank Bavin Independent Director
Bio & Compensation  - Reuters
Robert Gordon Reynolds Independent Director
Bio & Compensation  - Reuters
John C. Simmons Independent Director
Bio & Compensation  - Reuters